Medicare caps out-of-pocket costs at $5,000, expands aid for low-income seniors

What it does

This bill caps annual out-of-pocket costs for Medicare beneficiaries at $5,000 in 2028 (adjusted annually for inflation), after which Medicare covers 100% of remaining eligible costs. It also expands eligibility for low-income assistance programs (Medicare Savings Program and Low-Income Subsidy) by raising income thresholds to 200% of poverty and eliminating asset tests, while automating enrollment between programs to reduce bureaucratic barriers.

Why we flagged it

The bill's core mechanism is a straightforward out-of-pocket cost cap for Medicare beneficiaries, combined with expanded low-income eligibility. It is protective legislation, not a carve-out or subsidy to a narrow interest.

What the text implies

• The $5,000 cap applies only to Medicare Parts A and B (hospital and physician services), not Part D (prescription drugs), which has its own cost-sharing structure. Beneficiaries may still face high drug costs.
• The bill requires CMS to track and notify beneficiaries when they hit the cap, creating new administrative infrastructure; implementation delays or notification failures could leave beneficiaries unaware of their protection.
• Providers are prohibited from balance-billing above the reasonable charge once the cap is met, but enforcement depends on beneficiary awareness and willingness to challenge bills—vulnerable seniors may not assert their rights.
• The income-threshold increases (to 200% of poverty) for low-income programs take effect January 1, 2028, creating a two-year lag; current beneficiaries just below the new threshold remain ineligible until then.
• Elimination of asset/resource tests for LIS and MSP may increase enrollment but could also increase program costs, potentially triggering future pressure to tighten eligibility or reduce benefits elsewhere.

Who it affects

Ordinary Medicare beneficiaries gain direct financial protection—a hard cap on catastrophic out-of-pocket spending—and low-income seniors gain easier access to assistance programs with higher income thresholds and fewer eligibility hurdles. The primary beneficiaries are elderly and disabled Americans on fixed incomes.

Who stands to gain

• Medicare beneficiaries (direct)
• Low-income seniors and disabled individuals (direct)
• Pharmaceutical companies (potential negative—lower out-of-pocket spending may reduce price sensitivi
• Dialysis providers (DVA) (potential negative—capped costs reduce revenue per patient)
• Hospitals and physician practices (mixed—higher volume of fully-covered services post-cap, but lower

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Social Security Administration (SSA), Medicare Part A (hospital insurance), Medicare Part B (physician/outpatient services), Medicare Part D (prescription drug coverage), Low-Income Subsidy (LIS) program, Medicare Savings Program (MSP), Medicaid (Title XIX, Title XVI), Bristol Myers Squibb (BMY), Guardant Health (GH), Pfizer (PFE), DaVita (DVA) — and 1 more

Where it stands

16 cosponsors: 16 Democrats.

• Jun 24, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Jun 24, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $1,350,000 in lobbying spend. A filing names 72 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Lisa Blunt Rochester, the sponsor, reported $317,500 in PAC receipts in the 2026 cycle.

• AFL-CIO — $760,000 on 1 filing
• Blood Cancer United (fka the Leukemia & Lymphoma Society) — $590,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.